Methylnaltrexone | CAS 83387-25-1 - Request Quote
Methylnaltrexone
| SZ CAT No: | SZ-N068029 |
| CAS No | 83387-25-1 |
| Mol.F. | C21H26NO4 |
| Mol.Wt. | 356.4 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 73232-52-7 (bromide) ; 693784-16-6 (chloride) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Methylnaltrexone is chemically (3S,4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium. Methylnaltrexone is supplied with detailed characterization data compliant with regulatory guideline. Methylnaltrexone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Naltrexone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 83387-25-1
Purchase 83387-25-1
Order 83387-25-1
Enquire 83387-25-1
price of 83387-25-1
83387-25-1 Supplier
83387-25-1 Manufacturer
83387-25-1 Exporter
buy high quality Methylnaltrexone
Purchase Methylnaltrexone
Methylnaltrexone suppliers
Methylnaltrexone manufacturers
Methylnaltrexone price
Order Methylnaltrexone
Enquire Methylnaltrexone
Methylnaltrexone cost
Methylnaltrexone Supplier
Methylnaltrexone Distributor
Methylnaltrexone for Method Validation
Naltrexone Reference Standard
Methylnaltrexone for ANDA Filing
Methylnaltrexone for Forced Degradation Studies
Methylnaltrexone Identification Standards
Methylnaltrexone for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


